Ascendis Health Ltd
Ascendis Health Limited, a health and wellness company, provides health and wellness products and clinical and diagnostic medical devices in South Africa. It operates in Consumer Health and Medical Devices segments. The company offers multivitamins and minerals, micronutrients, and nutraceutical supplements; vitamins and homeopathic and herbal products; and over-the-counter, complementary, altern… Read more
Market Cap & Net Worth: Ascendis Health Ltd (ASC)
Ascendis Health Ltd (JSE:ASC) has a market capitalization of $30.61 Million (ZAC57.60 Billion) as of March 18, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #38454 globally and #155 in its home market, demonstrating a -4.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ascendis Health Ltd's stock price ZAC92.00 by its total outstanding shares 626045476 (626.05 Million).
Ascendis Health Ltd Market Cap History: 2015 to 2025
Ascendis Health Ltd's market capitalization history from 2015 to 2025. Data shows change from $651.14 Million to $30.61 Million (-24.58% CAGR).
Ascendis Health Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ascendis Health Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Ascendis Health Ltd's market cap is 0.02 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.58x
Ascendis Health Ltd's market cap is 0.58 times its annual earnings
9.21x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $834.44 Million | $3.92 Billion | $158.73 Million | 0.21x | 5.26x |
| 2017 | $581.71 Million | $6.44 Billion | $283.13 Million | 0.09x | 2.05x |
| 2018 | $136.72 Million | $5.51 Billion | $257.29 Million | 0.02x | 0.53x |
| 2019 | $49.95 Million | $5.87 Billion | -$4.71 Billion | 0.01x | N/A |
| 2020 | $24.65 Million | $6.96 Billion | -$965.81 Million | 0.00x | N/A |
| 2021 | $28.26 Million | $1.83 Billion | -$1.09 Billion | 0.02x | N/A |
| 2022 | $21.63 Million | $1.56 Billion | $449.20 Million | 0.01x | 0.05x |
| 2023 | $25.95 Million | $1.54 Billion | $75.32 Million | 0.02x | 0.34x |
| 2024 | $33.27 Million | $1.47 Billion | $57.29 Million | 0.02x | 0.58x |
Competitor Companies of ASC by Market Capitalization
Companies near Ascendis Health Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Ascendis Health Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Ascendis Health Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Ascendis Health Ltd's market cap moved from $651.14 Million to $ 30.61 Million, with a yearly change of -24.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ZAC30.61 Million | -8.00% |
| 2024 | ZAC33.27 Million | +28.21% |
| 2023 | ZAC25.95 Million | +20.00% |
| 2022 | ZAC21.63 Million | -23.48% |
| 2021 | ZAC28.26 Million | +14.67% |
| 2020 | ZAC24.65 Million | -50.66% |
| 2019 | ZAC49.95 Million | -63.46% |
| 2018 | ZAC136.72 Million | -76.50% |
| 2017 | ZAC581.71 Million | -30.29% |
| 2016 | ZAC834.44 Million | +28.15% |
| 2015 | ZAC651.14 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ascendis Health Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.61 Million USD |
| MoneyControl | $30.61 Million USD |
| MarketWatch | $30.61 Million USD |
| marketcap.company | $30.61 Million USD |
| Reuters | $30.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.